| |
| GDxPRO: Clinically proven performance |
| |
Confidently assess patients suspected of having glaucoma.
- A number of clinical studies have verified the correlation between RNFL measurements by GDx and glaucomatous damage.1,2,3,4
- Hundreds of published studies support the conclusion that GDx technology provides invaluable information for early disease detection and ongoing clinical management.
- GDx measurements are compared to an age-stratified, multi-ethnic normative database, providing you with a unique visual representation.
- The GDxPRO provides a unique and comprehensive view of RNFL health simply not available in other imaging technologies.
| 1 | Weinreb RN, Bowd C and Zangwill LM. Glaucoma detection using scanning laser polarimetry with variable corneal polarization compensation. Arch Ophthalmol. 2003; 121: 218–224. |
| 2 | Bagga H, Greenfield DS, Feuer W, and Knighton RW. Scanning laser polarimetry with variable corneal compensation and optical coherence tomography in normal and glaucomatous eyes. Am J Ophthalmol. 2003; 135: 521–529. |
| 3 | Mohammadi K, Bowd C, Weinreb RN, Medeiros FA, Sample PA, and Zangwill LM. Retinal nerve fiber layer thickness measurements with scanning laser polarimetry predict glaucomatous visual field loss. Am J Ophthalmol. 2004; 138: 592–601. |
| 4 | Cense B, Chen TC, Park BH, Pierce MC, and de Boer JF. Thickness and birefringence of healthy retinal nerve fiber layer tissue measured with polarization sensitive optical coherence tomography. Invest Ophthalmol Vis Sci. 2004; 45: 2606–2612. |
| |
|